Aprea Therapeutics, Inc.

Aprea Therapeutics, Inc. financial statements

Aprea Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 285.76KEODHD
Net income−USD 12.6M10-K
Cash and equivalentsUSD 14.6M10-Q

Aprea Therapeutics, Inc. financials on 6ix · Aprea Therapeutics, Inc. on 6ix